Several earlier clinical studies used CD14+CD16+ as the inflammatory monocyte criteria and established the association of increased levels of CD14+CD16+ monocyte in human inflammatory diseases, including rheumatoid arthritis, coronary arterial disease, atherosclerosis, hemophagocytic syndrome, and Crohn’s disease (Table 3). The gene discussed is CD14; the disease is atherosclerosis.